'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles

Brasil Notícia Notícia

'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 CNBC
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 72%

Two experts see major challenges facing the adoption of Novo Nordisk and Eli Lilly's obesity drugs.

on Ozempic's ability to delay the progression of chronic kidney disease is among the strongest supporting evidence for secondary uses of the drug." on Wednesday. "We have a long way to go for that. I've seen a lot of miracle drugs before."on Tuesday. According to the company's press release, it happened more than a year after an interim analysis showed that Ozempic could treat chronic kidney disease in Type 2 diabetic patients.

"We know this drug works really well in diabetics. But there are so many barriers to getting there —including cost, adherence, prescriber rate," said Patel, who also served as a White House Health Policy Director under President Obama. "Right now, we are seeing active employers, entire states that are declining to cover on the weight loss indication," Patel said.If the U.S. Food and Drug Administration approves Ozempic for use in Type 2 diabetics with chronic kidney disease, which Patel believes will happen, it could force the hand of insurance companies to expand their coverage of the drug.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

CNBC /  🏆 12. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

‘Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles‘Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdlesTwo experts see major challenges facing the adoption of Novo Nordisk and Eli Lilly’s obesity drugs.
Consulte Mais informação »

Two negatives are two positives for the FedTwo negatives are two positives for the FedOutlook: Today we get import prices, the Philly Fed’s Harker, and the University of Michigan consumer sentiment index(expected down to 67.4 in Oct fro
Consulte Mais informação »

Two arrested, two sought in connection with shots fired in EnterpriseTwo arrested, two sought in connection with shots fired in EnterpriseWith Israeli hostages and Palestinian civilians trapped inside Gaza, overseas family members of innocent people caught in the conflict feel powerless. In Brussels where the European Union is headquartered, our reporter Rosie Birchard met some of those hoping and praying that their loved ones will make it out alive.
Consulte Mais informação »

Colorado's two-way star Travis Hunter scores two touchdowns in return from lacerated liverColorado's two-way star Travis Hunter scores two touchdowns in return from lacerated liverTwo-way standout Travis Hunter returned from a lacerated liver that sidelined him for three games and played the roles of both hero and goat in Colorado's 46-43 collapse against Stanford.
Consulte Mais informação »

Risk-taker's market? Why it may be practical to take chips off the tableRisk-taker's market? Why it may be practical to take chips off the tableTwo market experts tackle the appropriate appetite for risk during market ugliness.
Consulte Mais informação »

GOP tensions reach a boiling point as Steve Scalise strugglesGOP tensions reach a boiling point as Steve Scalise strugglesOne Republican said it would be 'literally a miracle' if they elect a speaker on Thursday.
Consulte Mais informação »



Render Time: 2025-02-26 21:57:00